Although much has been published about the adequacy of dialysis and the effect of dialysis dose on morbidity and mortality in peritoneal dialysis patients, much less is known about when dialysis should be initiated. There are several advantages of using peritoneal dialysis for "early start" dialysis compared to hemodialysis, including lifestyle, diet and cost benefits. Several small studies on incremental peritoneal dialysis are reviewed in this article, and they provide conflicting results with regard to patient morbidity and mortality. In addition, there are peritoneal dialysis-related risks to incremental dialysis, including peritonitis, hernias and catheter-related complications. Since none of these studies were performed using a randomized cohort, it is unclear how selection bias and study design may have influenced the results reported. A large randomized trial of "early start" versus "standard start" dialysis is needed to help determine the potential risks and benefits of incremental peritoneal dialysis. Such a study is presently underway in Australia and New Zealand, and results from this study should be available in 2008. [Hong Kong J Nephrol 2005;7(2):59-64] 
INTRODUCTION
A number of investigators have tried to determine how to improve survival and morbidity in chronic peritoneal dialysis patients. Several large randomized multicenter trials have been performed to investigate the influence of an increase in the dose of dialysis on mortality and morbidity in peritoneal dialysis patients [1] [2] [3] [4] . Much less is known, however, about the potential risks and benefits of starting patients on dialysis at different levels of glomerular filtration rate (GFR). In the United States, most patients are started on renal replacement therapy when the GFR is < 10 mL/min/1.73 m 2 . Data on starting dialysis at higher levels of GFR are conflicting. Some studies have shown that there is no association between residual kidney function at the initiation of dialysis and mortality or morbidity [5] [6] [7] [8] , while other investigators have found a relationship between lower levels of residual kidney function and improved mortality and morbidity [9, 10] . These studies are confounded by two factors. First, observational data from the United States, Canada, and the United Kingdom registries [11, 12] suggest that patients with an increased number of comorbid medical conditions initiate dialysis at higher levels of estimated GFR compared to "healthier" patients. Second, almost all of these studies rely on the use of serum creatinine levels to estimate the patient's GFR. The use of these estimating equations is problematic since reduced muscle mass, and hence abnormally low serum creatinine levels, are seen in patients with significant medical comorbidities, such as leg amputations, angina severe enough to limit physical activity, strokes causing paralysis, lung diseases requiring oxygen therapy, etc. Thus, these creatinine-based estimates of GFR will overestimate residual renal function in patients who have comorbidities that result in decreased muscle mass.
INCREMENTAL DIALYSIS -HEMODIALYSIS OR PERITONEAL DIALYSIS?
If there is a benefit to starting dialysis at a higher level of GFR, then there are several potential advantages of initiating dialysis with peritoneal dialysis [13] . First, a number of studies have shown that residual renal function is better preserved with peritoneal dialysis than with hemodialysis, even after accounting for the improved preservation of residual renal function in hemodialysis with synthetic membranes [14] [15] [16] [17] . Second, the use of peritoneal dialysis delays the need for creating and using blood access sites. Third, due to the more continuous nature of peritoneal dialysis, there should be better control of sodium and water balance earlier in the course of advanced chronic kidney disease. Fourth, peritoneal dialysis allows for continued liberalization of the diet, which increases the likelihood that the patient will avoid malnutrition. Fifth, the cost of providing incremental peritoneal dialysis is less than that for incremental in-center hemodialysis. Finally, there are lifestyle benefits of peritoneal dialysis in terms of flexibility in providing the dialysis therapy at the patient's convenience, and in terms of increasing the dose of dialysis as needed as residual kidney function declines.
STUDIES ON INCREMENTAL DIALYSIS
The first study on incremental dialysis was performed in hemodialysis patients by Bonomini et al in the 1980s [18, 19] . In his study, 82 patients over a period of 15 years were started on a regimen of hemodialysis 2 times per week. In these 82 patients, the mean creatinine clearance at the start of dialysis was 11 mL/min. These patients were maintained on two hemodialysis sessions per week for 1-2 years, and then switched to three times per week hemodialysis. In a control group of 308 patients, chronic kidney disease was treated with a low protein diet for 24-53 months prior to initiating dialysis, when the creatinine clearance was 2.1-4.8 mL/min. The results of this study are shown in Table 1 and demonstrate that the patients starting hemodialysis early have lower mortality and morbidity.
A summary of the parameters for the four studies performed in peritoneal dialysis patients is shown in Table 2 , and the patient characteristics for these four studies are shown in Table 3 . The largest study, both in terms of number of patients and follow-up months, was conducted by Foggensteiner et al in the United Kingdom [20] . Thirty-nine patients with early symptoms of uremia, a slow decline in residual kidney function, and a Kt/V urea of more than 2.0 were enrolled into the study. The mean follow-up was 582 days (range, 1-1,836 days), and there were no patient deaths. All patients were initially started on a single overnight continuous ambulatory peritoneal dialysis exchange of 1-2 L. The number of exchanges was increased as needed to maintain a weekly Kt/V of more than 2.0. The median time on a single exchange before requiring an increase in the number of peritoneal dialysis exchanges was 297 days. Twenty-six patients (67%) remained on peritoneal dialysis, eight of whom remained on a single daily exchange at the conclusion of the study. Five patients received a renal transplant and eight patients transferred permanently to hemodialysis. Four patients were on a single peritoneal dialysis exchange at the time of the change to hemodialysis. In these four patients, the reason for transfer included Gram-negative peritonitis associated with diverticular disease, recurrent sterile peritonitis, pleural leak and catheter failure. During the period when patients were on one exchange, there were 14 hospital admissions of 12 patients for a total of 57 hospital days, representing 1.64 days per patient-year during the 35 patient-years of observation. Thirty-eight of these hospital days were for peritoneal dialysis-related indications such as hernia repair, peritonitis, pleural leaks and catheter exchanges. The rate of loss of residual kidney function while patients were receiving a single overnight exchange varied greatly among individual patients, with a mean annual decline of 31 L/week/ 1.73 m 2 for creatinine clearance and 0.60 for weekly Kt/V. De Vecchi's group from Milan, Italy, reported on 25 patients enrolled in their incremental peritoneal dialysis study [21] . At this center, patients prior to 1995 were started on dialysis when either the creatinine clearance was 3-4 mL/min or the patient began to develop uremic symptoms. Since 1995, patients with a creatinine clearance of 6-10 mL/min were given the opportunity to start with incremental peritoneal dialysis. Patients were started on a single exchange with an overnight dwell. If they showed a rapid decline in kidney function, they were started on two exchanges per day with a total dwell time of 12 hours/day. In all patients, the Kt/V urea was maintained at more than 1.5 by increasing the number of exchanges. During the period when patients were on 1-2 peritoneal dialysis exchanges per day, all patients remained on peritoneal dialysis except for one patient who received a kidney transplant. For the entire follow-up period, one patient died, four transferred to hemodialysis, and two received a kidney transplant. Data from this study are presented in Table 4 . Although the sample size was small, there were no statistically significant differences in the rates of hospitalization among patients receiving 1-2 exchanges per day versus patients receiving 3-4 exchanges per day.
Two smaller studies were conducted in North Carolina in the United States and in Alba, Italy. In the North Carolina study, 13 patients were begun on incremental peritoneal dialysis for one or more of the following reasons: weight loss, mild uremic symptoms, declining normalized protein nitrogen appearance to a level less than 0.8 g/kg/day, declining serum albumin level to 3.0 g/dL or less [22] . Thus, unlike the other studies cited, patients were enrolled in the North Carolina study if they had signs or symptoms of early uremia indicating the need to start dialysis therapy. The protocol for incremental peritoneal dialysis was based on body size, as measured by body surface area, and on the GFR at initiation of dialysis. Those patients with a GFR of 10-12 mL/min were started on one overnight exchange, while those with a GFR of 7-9 mL/min were started on one overnight exchange and an additional 5hour dwell. The annual mortality rate in the incremental group was 22.6% compared to 9.8% in a control group of patients on standard peritoneal dialysis. One patient died from complications of aortic valve surgery, a second patient died from complications of pneumonia with empyema and resulting sepsis, and a third patient died from peritonitis with Pseudomonas aeruginosa bacteremia. The leak and hernia rate was 0.151 per patient-year in the incremental peritoneal dialysis group and 0.063 per patient-year in the standard peritoneal dialysis group. The peritonitis rate was 0.226 per patient-year in the incremental peritoneal dialysis group and 0.398 per patient-year in the standard peritoneal dialysis group. The rate of loss of residual kidney function also varied among individual patients, with a mean annual decline of 44 L/week/1.73 m 2 for creatinine clearance and 0.66 for weekly Kt/V, slightly higher than that reported in the Foggensteiner et al study.
The Italian study from Alba is the only one to use automated or cycler dialysis for incremental dialysis [23] . Five patients with an initial GFR of 8-9 mL/min/ 1.73 m 2 were started on "low-frequency" automated peritoneal dialysis 3-4 days per week, with or without a full abdomen during the period between night-time exchanges. Three patients remained on low-frequency automated peritoneal dialysis at 15, 22, and 25 months of follow-up. Another patient had to increase the frequency of peritoneal dialysis due to a clinical assessment of under-dialysis, and a fifth patient transferred to hemodialysis after the patient refused to increase the number of days of peritoneal dialysis per week. No episodes of peritonitis occurred during a total follow-up of 84 patient-months on low frequency automated peritoneal dialysis.
One final study examined the nutritional status of patients receiving incremental peritoneal dialysis. Caravaca et al reported on nine patients who were started on incremental peritoneal dialysis and had 3-day diet histories obtained at 6 and 9 months after starting incremental peritoneal dialysis, and again at 6 and 9 months after these patients lost residual renal function and had to increase the peritoneal dose of dialysis [24] . Despite a decline in residual kidney urea clearance from 0.66 to 0.06 (p < 0.01), the patients had an increase in body weight from 59.6 kg to 63.9 kg (p = 0.01), and no change in serum albumin levels. Not surprisingly, there was an increase in peritoneal glucose uptake from 274 101 kcal/day to 344 81 kcal/day (p = 0.043), a decrease in dietary protein intake from 1.08 0.31 g/kg/day to 0.89 0.31 g/kg/day (p = 0.011), and a decrease in total energy intake from 37.6 10.2 kcal/kg/day to 32.8 9.0 kcal/kg/day (p = 0.025).
INCREMENTAL PERITONEAL DIALYSIS PRESCRIPTION
Another area of incremental peritoneal dialysis that will require additional research is the prescription provided to patients. Several investigators have reported on peritoneal clearance data on patients receiving incremental peritoneal dialysis; this data is summarized in Table 5 [21, 25] . Not surprisingly, the clearance of small solutes, such as urea and creatinine, increases as the number of exchanges increases. For these small molecules, there was no statistically significant increase in clearance when the dwell time was increased from 12 hours to 24 hours. For middle molecules, however, the duration of exchange is the most important factor in determining clearance. Thus, 2-microglobulin clearance was noted to be 5.4 2.7 L/week for a 12hour exchange but 9.1 2.6 L/week for a 24-hour dwell. Additional research is needed to determine if improved clearance of middle molecules as provided with longer exchanges will have beneficial effects on patient morbidity and mortality.
NEED FOR MORE RESEARCH
There is still much information that needs to be obtained about the potential risks and benefits of incremental peritoneal dialysis. The existing studies have reported on small numbers of patients, and the patient characteristics were different among these studies. There are conflicting results for patient mortality and morbidity, as compared to standard peritoneal dialysis. In addition, since patients were selected for incremental peritoneal dialysis, it is not known if selection bias between study patients and control patients accounts for some of the observed differences between groups. Important clinical design questions that need to be answered include: • What is the proper time to begin dialysis, even with an incremental schedule? • Is there any benefit to providing longer dwell times to increase the clearance of middle molecules? • Is there a benefit to starting with two long exchanges instead of one long exchange? Before incremental peritoneal dialysis can be recommended as standard therapy, the following outcome questions will need to be answered: • Does incremental peritoneal dialysis improve morbidity and mortality compared to standard peritoneal dialysis or hemodialysis? • Does incremental peritoneal dialysis have any effect on the preservation of residual kidney function? • Does incremental peritoneal dialysis have any effect on preservation of the peritoneal membrane?
The Initiating Dialysis Early and Late (IDEAL) study will help to answer some, if not most, of these outcome questions [26] . This study, being conducted in dialysis units throughout Australia and New Zealand, will randomize patients to start dialysis at a GFR (as measured by Cockcroft and Gault) of either 10-14 mL/ min/1.73 m 2 ("early start") or 5-7 mL/min/1.73 m 2 ("late start"). Patients will be stratified by dialysis modality (hemodialysis or peritoneal dialysis), study center, and the presence or absence of diabetes mellitus. It is recommended that patients on peritoneal dialysis have a weekly Kt/V of more than 2.0 (or 2.2 if on automated peritoneal dialysis), but these are considered targets and study centers are not required to provide this level of dialysis dose. The primary outcome for the study will be all-cause mortality, and the study is powered to detect a 10% difference in mortality rates with a two-sided significance of 0.05 and a power of 0.8. Secondary outcomes will include cardiovascular mortality, infectious complications, dialysis complications, total days of hospitalization, rate of decline in residual renal function and its independent effect on mortality and morbidity, nutritional status, quality of life, and economic impact. Data will be collected at 3-month intervals, and patients will be followed for 3 years. As of early 2004, more than 400 patients have been randomized into this study. It is anticipated that follow-up will be complete by December 2007, and that the results from the study will be available in 2008.
